It has been shown in this laboratory that PEITC is a HDAC inhibitor and can suppress HDAC enzyme activity and decrease HDAC enzyme expression in prostate cancer, leukemia, and myeloma cells [12-14,37-40]. The gene discussed is HDAC9; the disease is prostate carcinoma.